Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Antivir Ther. 2018;23(4):315–324. doi: 10.3851/IMP3199

Table 2.

Changes in Variables after 12 Months of Vitamin D Supplementation

A. Absolute Changes over 12 Months

Median (quartile 1, quartile 3) All Subjects (N=51) P Standard Dose (N=21) P Moderate Dose (N=18) P High Dose¥ (N=12) P P*
25(OH)D, ng/mL +15.6 (+9.2, +30.1) <0.0001 +14.7 (+12.0, +18.1) <0.0001 +19.2 (+10.0, +32.0) <0.0001 +31.0 (+16.2, +41.1) <0.0001 0.001
Body mass index, kg/m2 +0.67 (−0.49, +1.38) 0.02 +0.56 (−0.4, +0.9) 0.18 +1.4 (−0.37, +1.9) 0.01 +0.3 (−1.1, +3.1) 0.94 0.23
Current CD4, cells/mm3 +24 (−108, +154) 0.40 −1 (−118, +127) 0.72 +52 (−167, +137) 0.87 +62 (−50, +228) 0.34 0.66
Current CD8, cells/mm3 −23 (−147, +123) 0.84 −59 (−168, +129) 0.86 −56 (−205, +93) 0.61 +36 (−112, +234) 0.67 0.67
CD4/CD8 ratio +0.05 (−0.05, +0.18) 0.03 +0.03 (−0.7, +0.13) 0.47 +0.06 (−0.06, +0.18) 0.076 +0.05 (−0.01, +2.7) 0.13 0.65

B. Variables at 12 Months

Median (quartile 1, quartile 3) All Subjects (N=51) Standard Dose (N=21) Moderate Dose (N=18) High Dose¥ (N=12) P*

25(OH)D, ng/mL 36.5 (30.2, 43.0) 31.5 (23.8, 36.5) 37.8 (30.6, 42.0) 51.5 (37.6 (27.0, 58.5) 0.001
Body mass index, kg/m2 21.7 (10.0, 25.4) 20.7 (17.8, 23.2) 22.2 (20.0, 28.1) 22.6 (20.4, 24.7) 0.12
Current CD4, cells/mm3 703 (515, 948) 665 (554, 812) 689 (498, 961) 783 (456, 1122) 0.63
Current CD8, cells/mm3 650 (505, 908) 713 (508, 937) 630 (477, 761) 684 (506, 1015) 0.75
CD4/CD8 ratio 1.0 (0.8, 1,5) 0.9 (0.6, 1.3) 1.2 (0.8, 1.5) 1.0 (0.9, 1.6) 0.39

N.B. P-values with bolded font designate those <0.05;

P value within group;

*

P value among the three dosing groups;

Standard dose = 18,000 IU given monthly for 12 months (equivalent to 600 IU/daily);

Moderate dose = 60,000 IU given monthly for 12 months (equivalent to 2,000 IU/daily);

¥

High dose = 120,000 IU given monthly for 12 months (equivalent to 4,000 IU/daily).

25(OH)D, 25-hydroxyvitamin D